Cargando…
5-hydroxymethylcytosine marks regions with reduced mutation frequency in human DNA
CpG dinucleotides are the main mutational hot-spot in most cancers. The characteristic elevated C>T mutation rate in CpG sites has been related to 5-methylcytosine (5mC), an epigenetically modified base which resides in CpGs and plays a role in transcription silencing. In brain nearly a third of...
Autores principales: | Tomkova, Marketa, McClellan, Michael, Kriaucionis, Skirmantas, Schuster-Boeckler, Benjamin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931910/ https://www.ncbi.nlm.nih.gov/pubmed/27183007 http://dx.doi.org/10.7554/eLife.17082 |
Ejemplares similares
-
Mutational signature distribution varies with DNA replication timing and strand asymmetry
por: Tomkova, Marketa, et al.
Publicado: (2018) -
Modular Oxidation of
Cytosine Modifications and Their
Application in Direct and Quantitative Sequencing of 5-Hydroxymethylcytosine
por: Xu, Haiqi, et al.
Publicado: (2023) -
5-hydroxymethylcytosine marks promoters in colon that resist DNA hypermethylation in cancer
por: Uribe-Lewis, Santiago, et al.
Publicado: (2015) -
Marked synergy by vertical inhibition of EGFR signaling in NSCLC spheroids shows SOS1 is a therapeutic target in EGFR-mutated cancer
por: Theard, Patricia L, et al.
Publicado: (2020) -
Telomere length and genetics are independent colorectal tumour risk factors in an evaluation of biomarkers in normal bowel
por: Fernandez-Rozadilla, Ceres, et al.
Publicado: (2018)